Monday, October 22, 2007

[Development news] Apparent success with experimental malaria vaccine

Many news outlets reported on the apparent success of an experimental malaria vaccine that was administered to infants.

A clinical trial in Mozambique of 214 infants aged 10 to 18 weeks found the vaccine was safe and reduced new infections by 65 percent over a three-month period after treatment. Clinical illness was cut by 35 percent over six months.

A new vaccine could be commercially available in 2012, according to Reuters.

No comments: